IRF1 and neoplasm: Another study revealed that high expression of MUC1-C in TNBC is closely associated with the absence of tumor-infiltrating lymphocytes (TILs), and its synergistic action with PBRM1 enhances STAT1 and IRF1 expression in the interferon pathway, affecting T and NK cell functions and promoting tumor DNA damage resistance and immune escape (96).